Loading…
Cohance Lifesciences (COHANCE)₹443.65+0.37%Pharmaceuticals
At the end of the Jun 2026 quarter, Cohance Lifesciences' shareholders were: promoters 57.53%, FIIs 6.46%, DIIs 20.05%, government 0.01%, public 15.95%. Promoter holding is unchanged on the quarter. FII holding is down 0.73 percentage points from 7.19% a year earlier. 94.56% of promoter shares were pledged. It had 99,138 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 60.04% | 60.04% | 50.14% | 50.14% | 50.14% | 50.14% | 50.14% | 66.45% | 57.53% | 57.53% | 57.53% | 57.53% |
| FIIs | 9.97% | 10.10% | 9.50% | 9.76% | 10.66% | 10.80% | 11.01% | 7.19% | 6.47% | 5.97% | 5.56% | 6.46% |
| DIIs | 14.09% | 15.90% | 17.20% | 17.38% | 16.91% | 16.63% | 16.56% | 11.36% | 20.77% | 21.53% | 21.75% | 20.05% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 15.89% | 13.95% | 23.15% | 22.71% | 22.28% | 22.42% | 22.28% | 14.99% | 15.22% | 14.96% | 15.15% | 15.95% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 94.56% |
| Number of shareholders | 73,707 | 70,044 | 68,924 | 65,770 | 69,329 | 84,201 | 86,316 | 80,901 | 75,276 | 81,868 | 85,221 | 99,138 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Behryanda Limited | Promoter | 33.32% | 0.00 |
| Jusmirial Holdings Limited | Promoter | 24.09% | 0.00 |
| Dsp Regular Savings Fund | DII | 4.29% | New |
| Icic Preduential Health Care And Diaganostic | DII | 4.20% | New |
| Jasub Property Holdings Llp | Public | 3.86% | 0.00 |
| Sbi Mnc Fund | DII | 3.35% | New |
| Jasti Property And Equity Holdings Private Limited | Public | 2.50% | 0.00 |
| Hdfc Trustee Company Limited - Hdfc Tax Saver Fund | DII | 2.18% | New |
| Sbi Life Insurance Co. Ltd | DII | 1.76% | −0.27 |
| Invesco India Contra Fund | DII | 1.70% | +0.25 |
| Dsp Nifty Smallcap 250 Etf | DII | Exited | — |
| Icici Prudential Value Fund | DII | Exited | — |
| Hdfc Mutual Fund - Hdfc Bse 500 Etf | DII | Exited | — |
Promoters held 57.53% of Cohance Lifesciences at the end of the Jun 2026 quarter, down 8.92 percentage points from 66.45% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 6.46% (up 0.90 percentage points from 5.56% a quarter earlier) and domestic institutions (DIIs) held 20.05% (down 1.70 percentage points from 21.75% a quarter earlier).
Yes. 94.56% of promoter shares were pledged at the end of the Jun 2026 quarter.
Cohance Lifesciences had 99,138 shareholders at the end of the Jun 2026 quarter, against 80,901 a year earlier.
Dsp Regular Savings Fund (DII) held 4.29% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.